Event Information

イベントカレンダー

Well Characterized Biologicals

Event Information

実際のケーススタディから、分析戦略や法規制の見通しを学ぶ

Well Characterized Biologicals(十分に特性化された生物製剤:2011年学会)
2011年10月3日 - 5日, Omni Shoreham Washington, DC

諮問委員会

Izydor Apostol, Ph.D., Scientific Director, Analytical and Formulation Sciences, Amgen, Inc.

John P. Hennessey, Jr., Ph.D., Vice President, Research & Development, NovaDigm Therapeutics, Inc.

Alan V. Klotz, Ph.D., Research Advisor/CM&C Leader, Elanco Biosciences

Joseph Kutza, Ph.D., Director, CMC Regulatory Affairs, MedImmune, Inc.

Ned Mozier, Ph.D., Senior Director, Analytical Sciences, Global Biologics Research and Development, Pfizer, Inc.

Michael G. Mulkerrin, Ph.D., Vice President, Process Development, OncoMed Pharmaceuticals

Nadine M. Ritter, Ph.D., Senior CMC Consultant, Biologics Consulting Group

John Stults, Ph.D., Director of Protein Analytical Chemistry-2, Genentech, Inc.

Copyright IBC Life Sciences, a part of Informa Life Sciences Group | 日本語公式サイト運営 : IBC Life Sciences 代理店 株式会社グローバル インフォメーション

Powered by Interactive Agency Janmedia Interactive, Inc.